Physician profile
Matthew D Barber
NPI 1346338647
$158,128.25
in general payments reported to CMS, 2019-2025
39 companies · $42K in 2025
The $42K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $3,311 · 2021: $7,005 · 2022: $24K · 2023: $30K · 2024: $37K · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $75K · Royalty Or License: $19K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,100 · Travel and Lodging: $5,100 · Food and Beverage: $1,993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $75,375.75 |
| Royalty Or License | $18,815.03 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,100.00 |
| Travel and Lodging | $5,100.40 |
| Food and Beverage | $1,992.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intellijoint Surgical INC. | $51,650.00 | 2022-2025 | Intelljoint, Intellijoint Hip, Intellijoint Hip |
| Uoc USA INC | $31,513.55 | 2022-2025 | U2, Psi, Psi, Cones |
| Ortho Development Corporation | $27,602.11 | 2020-2025 | |
| Think Surgical, INC. | $16,495.76 | 2019-2023 | |
| Conformis, INC. | $14,188.31 | 2019-2021 | |
| Heron Therapeutics, INC. | $7,182.91 | 2022-2024 | Zynrelef, Aponvie |
| Globus Medical, INC. | $3,672.23 | 2021-2025 | Excelsiusgps Robotic Navigation System, Onvoy, Pelvic Screws |
| Medacta USA, INC. | $2,997.76 | 2020-2021 | |
| Smith+Nephew, INC. | $1,053.39 | 2020-2025 | Journey II, Lens 4k, N/A |
| Restor3d, INC. | $454.02 | 2023-2024 | |
| Stryker Corporation | $188.80 | 2019-2020 | |
| Depuy Synthes Sales INC. | $147.96 | 2019-2025 | |
| Boston Scientific Corporation | $82.46 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Prime Surgical, LLC | $78.09 | 2025 | |
| Medical Device Business Services, INC. | $71.01 | 2025 | Attune |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $68.93 | 2020-2024 | |
| Horizon Therapeutics Plc | $64.48 | 2019-2020 | |
| Zimvie INC. | $62.77 | 2022-2023 | |
| Kowa Pharmaceuticals America, INC. | $62.26 | 2022-2023 | Seglentis |
| Kyocera Medical Technologies, INC. | $45.10 | 2024 | |
| Amgen INC. | $40.71 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $39.96 | 2021 | |
| Bioventus LLC | $39.95 | 2021-2023 | Durolane |
| Sanofi-Aventis U.S. LLC | $35.36 | 2019 | |
| Relievant Medsystems, INC. | $31.07 | 2022 | |
| Kerecis Limited | $26.53 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Maxx Orthopedics, INC. | $26.43 | 2023 | |
| Djo, LLC | $25.77 | 2025 | Cmf |
| Becton, Dickinson and Company | $24.09 | 2024 | Arista Ah Flexitip |
| Vertex Pharmaceuticals Incorporated | $22.95 | 2025 | |
| Si-Bone, INC. | $21.65 | 2025 | |
| Engage Uni, LLC | $20.00 | 2021 | |
| Ferring Pharmaceuticals INC. | $18.54 | 2021 | |
| Pacira Therapeutics, INC. | $17.71 | 2019 | |
| Avanos Medical | $15.03 | 2020 | |
| Trice Medical, INC. | $14.28 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.30 | 2021 | |
| Onkos Surgical, INC. | $13.02 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$201,300.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Barber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.